Targeting Cdc42 improves motor phenotype in Parkinson's disease mice and reveals age-dependent susceptibility to α-synuclein. - Bopp V; LeeBae J; Oeckl P; Kühlwein JK; Grozdanov V; Kiechle M; Mayer B; Möhrle B; Geiger H; Danzer KM (IScience, 2025)